Search    ENTER KEYWORD
MSDS Material Safety Data Sheet
CAS

1312-41-0

File Name: 1312-41-0.asp

                                           MATERIAL SAFETY DATA SHEET



I PRODUCT IDENTIFICATION

Trade Name: Indium Antimonide CAS #:1312-41-0


II HAZARDOUS INGREDIENTS

Component: Percent: PEL: TLV:
0.5 mg Sb/m3, 0.1 mg In/m3 0.5 mg Sb/m3, 0.5 mg In/m3
Indium Antimonide 100


III PHYSICAL DATA

535 oC
Boiling Point 760 mm Hg: No data Freezing/Melting Point:
Specific Gravity (H2O=1): 5.75 (solid); 6.48 (liquid) Evaporation Rate: N/A
% Volatile by Volume: N/A Vapor Pressure: N/A
Reaction with H2O: None Solubility in H2O: Insoluble
Appearance and Odor: Silvery metal-like pieces or powder; odor not known.


IV FIRE AND EXPLOSION HAZARDS DATA

Flash Point (Method used): N/A

Special Fire Fighting Procedures: Indium antimonide will melt and fume in air at 500 oC. Antimony trioxide will be liberated. Use
normal firefighting procedures which include wearing NIOSH/MSHA approved self-contained breathing apparatus, flame and
chemical resistant clothing: hats, boots and gloves. If without risk remove material from fire area.

Extinguishing Media: Non-flammable. If involved in a fire, use dry chemical extinguishing agents, dry sand, or dry ground dolo-
mite.

Unusual Fire and Explosion Hazards: N/A


V HEALTH HAZARD INFORMATION

OSHA (PEL): 0.5 mg Sb/m3; 0.1 mg In/m3 ACGIH (TLV): 0.5 mg Sb/m3; 0.1 mg In/m3

Acute Effects:
Ingestion: None known. May cause effects similar to those of acute inhalation.
Skin Contact: May cause irritation. Eye Contact: May cause irritation.
Inhalation: May cause irritation. Dust or fumes may cause antimony nausea, vomiting, bloody diarrhea, dizziness, irritability, and
muscle pains. May cause liver damage.

Medical Conditions Aggravates by Chemical: None known.
Other Health Hazards: None known.
Most Likely Route of Entry: Ingestion.

Chronic Effects:
Ingestion: None known Skin Contact: May cause dermatitis
Eye Contact: None known
Inhalation: In humans exposed to antimony oxide fumes complaints referable to the nervous system have been reported.
Other: Animals exposed to antimony oxide fumes have developed
Effects of Over Exposure:

Inhalation: Overexposure to fused silica dust or condensed silica vapors for an extended period of time may produce lung injury.
Symptoms include coughing, wheezing and difficulty in breathing.

Ingestion: No adverse effects anticipated since material is insoluble and nontoxic.
Skin Contact: No adverse effects anticipated.
Eye Contact: Irritation due to mechanical abrasion.

EMERGENCY AND FIRST AID PROCEDURES:

EYE CONTACT: Flush eyes with water to remove particles.


IV REACTIVITY DATA

Stability: Stable
Incompatibility (Material to Avoid): N/A
Hazardous Polymerization: Will not occur


VII SPILL OR LEAK PROCEDURES

Steps to Be Taken in Case Material Is Released or Spilled: Use normal clean-up procedures, using a broom or vacuum, taking care
to avoid excessive dusting.

Waste Disposal Method: Dispose of in accordance with Local, State and Federal Waste Disposal Regulations.


VIII SPECIAL PROTECTION INFORMATION

Respiratory Protection: If exposure may exceed permissible limits, use a NIOSH-approved respirator for dust having a TLV not
less than 0.05 mg/m3. Always observe respirator limitations.

Ventilation Requirements: For cutting or grinding operations, use local exhaust ventilation if necessary, to keep exposure levels
below permissible limits.


IX SPECIAL PRECAUTIONS

Precautions to Be Taken in Handling and Storage: Normal precautions for handling potentially sharp, broken edged material.


Prepared by: S. Dierks
Dated: December 1993

ALL Chemical Analysis PAGES IN THIS GROUP
NAMECAS
7681-65-4.asp 7681-65-4 7553-56-2
1308-80-1.asp 1308-80-1
1317-38-0.asp 1317-38-0
20405-64-5.asp 20405-64-5
7440-50-8.asp 7440-50-8
1317-40-4.asp 1317-40-4
12019-52-2.asp 12019-52-2
12019-23-7.asp 12019-23-7
9002-84-0.asp 9002-84-0
espimetals_com_diammineplatinumnitride.asp N/A
espimetals_com_dysprosiumchloride.asp N/A
13569-80-7.asp 13569-80-7
espimetals_com_dysprosiumoxide.asp N/A
10025-75-9.asp 10025-75-9
13760-83-3.asp 13760-83-3
12159-66-9.asp 12159-66-9
13765-25-8.asp 13765-25-8
12008-06-9.asp 12008-06-9
10138-52-0.asp 10138-52-0
13765-26-9.asp 13765-26-9
10168-81-7.asp 10168-81-7 7697-37-2
25764-15-2.asp 25764-15-2
13450-88-9.asp 13450-88-9
13450-90-3.asp 13450-90-3
13450-91-4.asp 13450-91-4
13494-90-1.asp 13494-90-1
espimetals_com_galliumnitride.asp N/A
12024-21-4.asp 12024-21-4
12063-98-8.asp 12063-98-8
14024-24-7.asp 14024-24-7
12024-27-0.asp 12024-27-0
12024-14-5.asp 12024-14-5
7783-51-9.asp 7783-51-9
espimetals_com_goldacetate.asp N/A
866-84-2.asp 866-84-2 77-92-2
554-07-4.asp 554-07-4
13499-05-3.asp 13499-05-3
12656-74-5.asp 12656-74-5 11105-16-1
12055-23-1.asp 12055-23-1
13759-17-6.asp 13759-17-6
espimetals_com_hexachloroplatinicacid.asp N/A
13825-76-8.asp 13825-76-8
14483-18-2.asp 14483-18-2 7697-37-2
12055-62-8.asp 12055-62-8
1312-41-0.asp 1312-41-0
10025-82-8.asp 10025-82-8
espimetals_com_indiumnitrate.asp N/A
25617-98-5.asp 25617-98-5
1312-43-2.asp 1312-43-2
espimetals_com_indiumphosphide.asp N/A


HBCChem,Inc

Chemical Information Net chemcas.orgCopyright Reserved

Trading Lead

Leputech HPLC Laboratory